about
Hypomethylation and aberrant expression of the glioma pathogenesis-related 1 gene in Wilms tumorsFrequent long-range epigenetic silencing of protocadherin gene clusters on chromosome 5q31 in Wilms' tumor.Genome-wide DNA methylation analysis identifies MEGF10 as a novel epigenetically repressed candidate tumor suppressor gene in neuroblastomaThe parathyroid hormone-responsive B1 gene is interrupted by a t(1;7)(q42;p15) breakpoint associated with Wilms' tumour.A CTCF-binding silencer regulates the imprinted genes AWT1 and WT1-AS and exhibits sequential epigenetic defects during Wilms' tumourigenesis.Control of epigenetic states by WT1 via regulation of de novo DNA methyltransferase 3A.Characterization of 17.94, a novel anaplastic Wilms' tumor cell line.Alternately spliced WT1 antisense transcripts interact with WT1 sense RNA and show epigenetic and splicing defects in cancer.Long-range epigenetic silencing of chromosome 5q31 protocadherins is involved in early and late stages of colorectal tumorigenesis through modulation of oncogenic pathways.Perilobar nephrogenic rests are nonobligate molecular genetic precursor lesions of insulin-like growth factor-II-associated Wilms tumors.The APC Variant p.Glu1317Gln predisposes to colorectal adenomas by a novel mechanism of relaxing the target for tumorigenic somatic APC mutations.Inherited predisposition to colorectal adenomas caused by multiple rare alleles of MUTYH but not OGG1, NUDT1, NTH1 or NEIL 1, 2 or 3.Genomic imprinting at the WT1 gene involves a novel coding transcript (AWT1) that shows deregulation in Wilms' tumours.Multiple rare nonsynonymous variants in the adenomatous polyposis coli gene predispose to colorectal adenomas.Rapid recognition of aberrant dHPLC elution profiles using the Transgenomic NavigatorTM softwareEpigenetic deregulation of GATA3 in neuroblastoma is associated with increased GATA3 protein expression and with poor outcomes
P50
Q24678285-892ECE7A-97AE-40EF-B721-B278B243B169Q30945124-DE1FF327-8441-4B4C-9C59-0ED933193D5BQ33578303-2A184179-7976-486B-8449-D559E44BC2D8Q34181512-9722AFD6-B382-4785-85C2-CDDF3731C90EQ34599448-44B14254-AE82-4E99-8519-3FB268B4CD74Q39264413-D1E32C1C-8C70-49DB-A381-7C7858E9CA5DQ39322422-C1476267-59CB-485A-A9EE-1BAEC1596E68Q40189832-83A560F0-2B2A-4166-BD38-48EC03304EBFQ40492521-8CBB1CE3-0A62-4444-8EA5-0C502F6D61F3Q42056082-8304A1EA-E25C-4218-B9C9-A312DDAD8B78Q42631527-28CD34EC-1D1F-4169-8EF8-34F39D8622ADQ46565114-9BD11C0B-2999-4540-B185-54ABC4DD5307Q52957891-13791F4C-0202-4634-AA66-34F8798B6F80Q53552157-509ABF18-6C98-4029-82D1-90DAE07F8E86Q63722666-1A5C0B2B-14CF-474E-97B8-A82433BE03D1Q91933513-E393D9F6-AF65-4901-AA35-E81B4270328A
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anthony R Dallosso
@ast
Anthony R Dallosso
@en
Anthony R Dallosso
@es
Anthony R Dallosso
@nl
type
label
Anthony R Dallosso
@ast
Anthony R Dallosso
@en
Anthony R Dallosso
@es
Anthony R Dallosso
@nl
prefLabel
Anthony R Dallosso
@ast
Anthony R Dallosso
@en
Anthony R Dallosso
@es
Anthony R Dallosso
@nl
P106
P21
P31
P496
0000-0002-1460-2550